Treatment of epilepsy in children with developmental disabilities

Developmental Disabilities Research Reviews

Volumn 16, Issue 3, 2010, Pages 239-247

  Depositario Cabacar, Dewi Frances T ^a   Zelleke, Tesfaye Getaneh ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antiepileptic drugs; Cognitive and behavioral adverse effects; Developmental disabilities; Epilepsy; Pediatrics

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; BENZODIAZEPINE; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; FELBAMATE; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PIRACETAM; PRIMIDONE; TIAGABINE; TOPIRAMATE; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

AGGRESSION; AGGRESSIVENESS; AGITATION; ANXIETY; ATONIC SEIZURE; ATTENTION DEFICIT DISORDER; AUTISM; BEHAVIOR DISORDER; BRAIN DISEASE; CEREBRAL PALSY; CHILD; COGNITIVE DEFECT; CONFUSION; DEPRESSION; DEVELOPMENTAL DISORDER; DROWSINESS; ELECTROENCEPHALOGRAM; EPILEPSY; FOCAL EPILEPSY; HUMAN; HYPERACTIVITY; HYPERKINESIA; HYPOMANIA; IRRITABILITY; KETOGENIC DIET; LETHARGY; MENTAL RETARDATION MALFORMATION SYNDROME; MOOD DISORDER; MYOCLONUS SEIZURE; NERVOUSNESS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OPPOSITIONAL DEFIANT DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; REVIEW; SEDATION; SEIZURE; SIDE EFFECT; SOMNOLENCE; TONIC CLONIC SEIZURE; TONIC SEIZURE; VAGUS NERVE; VAGUS NERVE STIMULATION; COMORBIDITY; DRUG COMBINATION; DRUG EFFECT; DRUG INTERACTION; DRUG MONITORING; ELECTROENCEPHALOGRAPHY; MENTAL DEFICIENCY; MULTIMODALITY CANCER THERAPY; PROGNOSIS; VIDEORECORDING;

ANTICONVULSANTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; CHILD DEVELOPMENT DISORDERS, PERVASIVE; COMBINED MODALITY THERAPY; COMORBIDITY; DEVELOPMENTAL DISABILITIES; DRUG INTERACTIONS; DRUG MONITORING; DRUG THERAPY, COMBINATION; ELECTROENCEPHALOGRAPHY; EPILEPSY; HUMANS; MENTAL RETARDATION; PROGNOSIS; VIDEO RECORDING;

EID: 79952780951     PISSN: 19405510     EISSN: 10982779     Source Type: Journal    
DOI: 10.1002/ddrr.116     Document Type: Review

References (103)

1. Airaksinen EM, Natalainen R, Mononen T, et al. 2000. A population-based study on epilepsy in mentally retarded children. Epilepsia 41:1214-1220.
2. Aldenkamp AP, Alpherts WCJ, Blennow J, et al. 1993. Withdrawal of antiepileptic medication in children-effects on cognitive function. The multicenter Holmfrid study. Neurology 43:41.
3. Alvarez N, Besag F, Iivanainen M. 1998. Use of antiepileptic drugs in the treatment of epilepsy in people with intellectual disability. J Intellec Diasabil Res 42 (Suppl 1):1-15.
4. American Academy of Pediatrics. 2000. Subcommittee on attention-deficit/hyperactivity D, committee on quality l. Clinical practice guideline: diagnosis and evaluation the child's attention deficit/hyperactivity disorder. Pediatrics 105:1158-1170.
5. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th ed., text revision (DSM-IV-TR). Washington, DC: American Psychiatric Association.
6. Anderson GD. 2004. Pharmacogenetics and enzyme induction/inhibition properties of antiepileptic drugs. Neurology 63 (Suppl 4):S3-S8.
7. Arif H, Buchsbaum R, Weintraub D, et al. 2009. Patient reported cognitive side effects of antiepileptic drugs: predictors and comparison of all commonly used antiepileptic drugs. Epilepsy Behav 14:202-209.
8. Ashwal S, Russman BS, Blasco PA, et al. 2004. Quality standards subcommittee of the American academy of neurology: practice committee of the child neurology society. Practice parameter: diagnostic assessment of the child with cerebral palsy: report of the quality standards subcommittee of the American academy of neurology and the practice committee of the child neurology society. Neurology 62:851-863.
9. Baird G, Robinson RO, Boyd S, et al. 2006. Sleep electroencephalograms in young children with autism with and without regression. Dev Med Child Neurol 48:604-608.
10. Beran RG, Gibson RJ. 1998. Aggressive behavior in intellectually challenged patients with epilepsy treated with lamotrigine. Epilepsia 39:280-282.
11. Berg AT. 1995. The epidemiology of seizures and epilepsy in children. In: Shinnar S, Amir N, Branski D, editors. Childhood seizures. Basel: Karger. p 1-10.
12. Berg AT. 2008. Risk of recurrence after a first unprovoked seizure. Epilepsia 49 (Suppl 1): 13-18.
13. Besag FMC. 2002. Childhood epilepsy in relation to mental handicap and behavioral disorders. J Child Psychol Psychiatry 43:103-131.
14. Bootsma HPR, Aldenkamp AP, Diepman L, et al. 2006. The effect of antiepileptic drugs on cognition: patient perceived cognitive problems of topiramate versus levetiracetam in clinical practice. Epilepsia 47 (Suppl 2): 24-27.
15. Bourgeois BFD. 2002. Controlling seizures in children with developmental disabilities: an overview. In: Devinsky O, Westbrook LE, editors. Epilepsy and developmental disablities. Woburn, MA: Butterwork-Heinemann. p 281-285.
16. Bye AM, Kok DJ, Ferenschild FT, et al. 2000. Paroxysmal non-epileptic events in children: a retrospective study over a period of 10 years. J Paediatr Child Health 36:244-248.
17. Camfield C, Camfield P. 2007. Preventable and unpreventable causes of childhood-onset epilepsy plus mental retardation. Pediatrics 120:e52-55.
18. Camfield PR, Camfield CS. 2002. Initiating and discontinuing antiepileptic drugs in children with neurologic handicaps and epilepsy. In: Devinsky O, Westbrook LE, editors. Epilepsy and developmental disablities. Woburn, MA: Butterwork-Heinemann. p 281-285.
19. Camfield PR, Camfield CS, Dooley JM, et al. 1985. Epilepsy after a first unprovoked seizure in childhood. Neurology 35:1657-1660.
20. Canitano R, Lucchetti A, Zappella M. 2005. Epilepsy, electroencephalographic abnormalities and regression in children with autism. J Child Neurol 20:27-31.
21. Chen YJ, Chow JC, Lee IC. 2001. Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Res 44:65-70.
22. D'Amelio M, Shinnar S, Hauser WA. 2002. Epilepsy in children with mental retardation and cerebral palsy. In:Devinsky O, Westbrook L, editors. Epilepsy and developmental disabilities. Woburn, MA: Butterworth-Heinemann. p 3-16.
23. Danielsson S, Gillberg IC, Billstedt E, et al. 2005. Epilepsy in young adults with autism: a prospective population-based follow-up study of 120 individuals diagnosed in childhood. Epilepsia 46:918-923.
24. Delgado MR, Riela AR, Mills J, et al. 1996. Discontinuation of antiepileptic drug treatment after 2 seizure-free years in children with cerebral palsy. Pediatrics 97:192-197.
25. Deonna T, Roulet E. 2006. Autistic spectrum disorder: evaluating a possible contributing or casual role of epilepsy. Epilepsia 47 (Suppl 2):79-82.
26. Deyken, EY, MacMahon B. 1979. The incidence of seizures among children with autistic symptoms. Am J Psychiatry 136:1310-1312.
27. Donati F, Gobbi G, Campistol J, et al. 2006. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology 67:679-682.
28. Dooley J, Gordon K, Camfield P, et al. 1996. Discontinuation of anticonvulsant therapy in children free of seizures for one year: a prospective study. Neurology 46:969-974.
29. Dulac O, Chiron C, Cusmai R, et al. 1991. Viga-batrin in childhood epilepsy. J Child Neurol 6 (Suppl 2):2S30-2S37.
30. Dunn DW, Austin JK, Harezlak J, et al. 2003. ADHD and epilepsy in childhood. Dev Med Child Neurol 45:50-54.
31. Eriksson K, Erila T, Kivimaki T, et al. 1998. Evolution of epilepsy in children with mental retardation: five-year experience in 78 cases. Am J Ment Retard 102:464-472.
32. Forsgren L, Edvinsson SO, Blomquist HK, et al. 1990. Epilepsy in a population of mentally retarded children and adults. Epilepsy Res 6:234-248.
33. Glauser TA. 2004. Behavioral and psychiatric adverse events associated with antiepileptic drugs commonly used in pediatric patients. J Child Neurol 19 (Suppl 1):S25-S38.
34. Glauser TA, Ayala R, Elterman RD, et al. 2006. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 66:1654-1660.
35. Glauser TA, Dlugos DJ, Dodson WE, et al. 2007. Topiramate monotherapy in newly diagnosed epilepsy. J Child Neurol 22:693-699.
36. Gros-Tsur V, Manor O, van der Meere J, et al. 1997. Epilepsy and attention deficit hyperactivity disorder: is methylphenidate safe and effective? J Pediatr 130:670-674.
37. Gucuyuner K, Erdemoglu K, Senol S, et al. 2003. Use of methyphenidate for attention-deficit hyperactivity disorder in patients with epilepsy or electroencephalographic abnormalities. J Child Neurol 18:109-112.
38. Hadjipanayis A, Hadjichristodoulou C, Youroukos S. 1997. Epilepsy in patients with cerebral palsy. Dev Med Child Neurol 39:659-663.
39. Hagberg B, Hagberg G, Beckung E, et al. 2001. Changing panorama of cerebral palsy in Sweden. VIII. Prevalence and origin in the birth year period 1991-1994. Acta Paediatr 90:271-277.
40. Hauser WA, Rich SS, Lee JRJ, et al. 1998. Risk of recurrent seizures after 2 unprovoked seizures. N Engl J Med 338:429-434.
41. Hermann B, Jones J, Dabbs K, et al. 2007. The frequency, complications and aetiology of ADHD in new onset paediatric epilepsy. Brain 130:3135-3148.
42. Hessen E, Lossius MI, Reinvang I, et al. 2006. Influence of major antiepileptic drugs on attention, reaction time, and speed of information processing: results from a randomized, double blind, placebo-controlled withdrawal study of seizure-free epilepsy patients receiving monotherapy. Epilepsia 47:2038-2045.
43. Hirtz D, Ashwal S, Berg A, et al. 2000. Practice parameter: evaluating a first nonfebrile seizure in children: report of the quality standards subcommittee of the American academy of neurology. The child neurology society and the American epilepsy society. Neurology 55:616-623.
44. Holmes GL. 2002. Childhood-specific epilepsies accompanied by developmental disabilities: causes and effects. In:Devinsky O, West-brook LE, editros. Epilepsy and developmental disabilities. Woburn, MA: Butter-worth-Heinemann. p 23-40.
45. Hosking G, Miles R, Winstanley P. 1990. Seizures in patients with cerebral palsy. Dev Med Child Neurol 32:1026-1027.
46. Hundozi-Hysenaj H, Boshnjaku-Dallku I. 2008. Epilepsy in children with cerebral palsy. J Pediatr Neurol 6:43-46.
47. Kang HC, Eun BL, Lee CW, et al. 2007. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 48:1716-1723.
48. Kaufmann R, Goldberg-Stern H, Shuper A. 2009. Attention deficit disorders and epilepsy in childhood: incidence. Causative relations and treatment possibilities. J Child Neurol 24:727-733.
49. Ketter TA, Post RM, Theodore WH. 1999. Positive and negative psychiatric effects of antie-pileptic drugs in patients with seizure disorder. Neurology 53(5,Suppl 2):S53-S67.
50. Kothare SV, Kaleyias J, Mostofi N, et al. 2006. Monotherapy in a cohort of children with epilepsy. Pediatr Neurol 34:351-354.
51. Kwan P, Brodie MJ. 2001. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357:216-222.
52. Lagae L. 2006. Cognitive side effects of anti-epileptic drugs: the relevance in childhood epilepsy. Seizure 15:235-241.
53. Lee DO, Steingard RJ, Cesena M, et al. 1996. Behavioral side effects of gabapentin in children. Epilepsia 37:87-90.
54. Levinson DF, Devinsky O. 1999. Psychiatric adverse events during vigabatrin therapy. Neurology 53:1503-1511.
55. Levisohn, PM. 2007. The autism-epilepsy connection. Epilepsia 48 (Suppl 9):33-35.
56. Levisohn PM, Mintz M, Hunter SJ, et al. 2009. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double- blind, placebo-controlled, noninferiority trial. Epilepsia 50:2377-2389.
57. Loring DW, Meadoer KJ. 2004. Cognitive side effects of antiepileptic drugs in children. Neurology 62:872-877.
58. Mangano S, Cusumano L, Fontana A. 2003. Non-convulsive status epilepticus associated with tiagabine in a pediatric patient. Brain Dev 25:518-521.
59. Mapstone TB. 2008. Vagus nerve stimulation: current concepts. Neurosurg Focus 25:E9.
60. McConell H, Snyder PJ, Duffy JD, et al. 1996. Neuropsychiatric side effects related to treatment with felbamate. J Neuropsychiatry Clin Neurosci 8:341-346.
61. Mouridsen SE, Rich B, Isager T. 1999. Epilepsy in disintegrative psychosis and infantile autism: a long term validation study. Dev Med Child Neurol 41:110-114.
62. Mula M, Monaco F. 2009. Antiepileptic drugs and psychopathology of epilepsy: an update. Epileptic Disord 11:1-9.
63. Mula M, Trimble MR, Sander JW. 2004. Psychiatric adverse events in patients with epilepsy and learning disabilities taking levetiracetam. Seizure 13:55-57.
64. National Institute for Clinical Excellence. 2004. Clinical guideline. CG20 The epilepsies-the diagnosis, and management of the epilepsies in adults and children in primary and secondary care. Available at: www.nice.org.uk.
65. Nelson KB, Ellenberg JH. 1978. Epidemiology of cerebral palsy. Adv Neurol 19:421-435.
66. Nordin V, Gillberg C. 1998. The long-term course of autistic disorders: update on follow-up studies. Acta Psychaitry Scand 97:99-108.
67. Olsson I, Steffenburg S, Gillberg C. 1988. Epilepsy in autism and autistic-like conditions. Arch Neurol 45:666-668.
68. Park SP, Hwang YU, Lee HW, et al. 2008. Long term cognitive and mood effects of zonisa-mide monotherapy in epilepsy patients. Epilepsia Behav 12:102-108.
69. Park SP, Kwon SH. 2008. Cognitive effects of antiepileptic drugs. J Clin Neurol 4:99-106.
70. Pellegrino L. 2000. Cerebral palsy. In: Batshaw M, editor. Children with disabilities, 4th ed. Baltimore: Paul H. Brookes. p 499-528.
71. Pellock JM. 1999. Felbamate. Epilepsia 40 (Suppl 5):S57-S62.
72. Pellock JM. 2003. Antiepileptic drugs in children with developmental delays and behavioral problems. Curr Treatment Opt Neurol 5:121-128.
73. Pellock JM, Hunt PA. 1996. A decade of modern epilepsy therapy in institutionalized mentally retarded patients. Epilepsy Res 25:263-268.
74. Perucca E. 2005. An introduction to antiepileptic drugs. Epilepsia 46 (Suppl 4):31-37.
75. Perucca E, Meador KJ. 2005. Adverse effects of antiepileptic drugs. Acta Neurol Scand 112 (Suppl 181):30-35.
76. Pina-Garza JE, Nordli DR Jr, Yang H, et al. 2009. Adjunctive levetiracetam in infants and young children with refractory partial-onset seizures. Epilepsia 50:1141-1149.
77. Polanczyk G, de Lima MS, Horta BL, et al. 2007. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry 164:942-948.
78. Pressler EM, Binnie CD, Coleshill SG, et al. 2006. Effect of lamotrigine on cognition in children with epilepsy. Neurology 66:1495-1499.
79. Rosenfeld WE, Roberts DW. 2009. Tonic and atonic seizures: what's next-VNS or callos-otomy? Epilepsia 50 (Suppl 8):25-30.
80. Sabaz M, Cairns DR, Lawson JA, et al. 2001. The health related quality of life of children with refractory epilepsy: a comparison of those with and without interllectural disability. Epilepsia 42:621-628.
81. Sankar R, Holmes G. 2004. Mechanism of Action for the commonly used antiepileptic drugs: relevance to antiepileptic drug-associated neurobehavioral adverse effects. J Child Neurol 19 (Suppl 1):S6-S14.
82. Schaller JL, Behar D. 1999. Carbamazepine and methylphenidate in ADHD. J Am Acad Child Adolesc Psychiatry 38:112-113.
83. Schmitz B. 2006. Effects of antiepileptic drugs on mood and behavior. Epilepsia 47 (Suppl 2):28-33.
84. Shinnar S, Berg AT, Moshe SL, et al. 1994. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol 35:534-545.
85. Smith MC. 2006. Optimizing therapy of seizures in children and adolescents with developmental disabilities. Neurology 67 (Suppl 4): S52-S55.
86. Steffenburg S, Gillberg C, Steffenburg U. 1996. Psychiatric disorders in children and adolescents with mental retardation and active epilepsy. Arch Neurol 53:904-912.
87. Stephenson JBP. 1999. Cerebral palsy. In: Engel J Jr, Pedley TA, editors. Epilepsy: a comprehensive textbook. Phialdelphia: Lippincott-Raven. p 2571-2577.
88. Sulzbacher S, Farwell JR, Temkin N, et al. 1999. Late cognitive effects of early treatment with Phenobarbital. Clin Pediatr 38:387-394.
89. Sunder TR. 1997. Meeting the challenge of epilepsy in persons with multiple handicaps. J Child Neurol 12 (Suppl 1):S38-S43.
90. Susova J, Seidl Z, Faber J. 1990. Hemiparetic forms of cerebral palsy in relation to epilepsy and mental retardation. Dev Med Child Neurol 32:792-795.
91. Susser M, Hauser WA, Kiely JL, et al. 1985. Quantitative estimates of prenatal and perinatal risk factors for perinatal mortality, cerebral palsy, mental retardation and epilepsy. In:Freedman JM, editor. Prenatal and perinatal factors associated with brain disorders. Bethesda, MD: National Institute of Health (NIH Publ No. 85-1149). p 359-439.
92. Tuchman RF. 2000. Treatment of seizure disorders and EEG abnormalities in children with autism spectrum disorders. J Autism Dev Disord 5:485-489.
93. Tan M, Appleton R. 2005. Attention deficit and hyperactivity disorder, methylphenidate, and epilepsy. Arch Dis Child 90:57-59.
94. Tuchman, RF, Rapin I. 1997. Regression in pervasive developmental disorders: seizure and epileptiform encephalogram correlates. Pediatrics 22:560-566.
95. Tuchman RF, Rapin I. 2002. Epilepsy in autism. Lancet Neurol 1:352-358.
96. Urdall P, Alving J, Hansen LK, et al. 2006. The misdiagnosis of epilepsy in children admitted to a tertiary epilepsy centre with paroxysmal events. Arch Dis Child 91:219-221.
97. Uvebrandt P. 1988. Hemiplegic cerebral palsy: aetiology and outcome. Acta Paediatr Scand (Suppl 345):65-68.
98. Vining EP, Mellitis ED, Cataldo MF, et al. 1987. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 80: 165-174.
99. Volkmar FR, Nelson DS. 1990. Seizure disorders in autism. J Am Acad Child Adolesc Psychiatry 29:127-129.
100. Wilfong AA. 2007. Monotherapy in children and infants. Neurology 69 (Suppl 3):S17-S22.
101. Willmore LJ, Abelson MB, Ben-Menachem E, et al. 2009. Vigabatrin: 2008 update. Epilepsia 50:163-173.
102. Wolf SM, Shinnar S, Kang H, et al. 1995. Gabapentin toxicity in children manifesting as behavioral changes. Epilepsia 36:1203-1205.
103. Zafeiriou DI, Kontopoulus EE, Tsikoulas I. 1999. Characteristics and prognosis of epilepsy in children with cerebral palsy. J Child Neurol 13:289-294.